These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 28806929)

  • 1. Myelination is delayed during postnatal brain development in the mdx mouse model of Duchenne muscular dystrophy.
    Aranmolate A; Tse N; Colognato H
    BMC Neurosci; 2017 Aug; 18(1):63. PubMed ID: 28806929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dmd mdx mice have defective oligodendrogenesis, delayed myelin compaction and persistent hypomyelination.
    Arreguin AJ; Shao Z; Colognato H
    Dis Model Mech; 2024 Apr; 17(4):. PubMed ID: 38721692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
    Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
    Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased plasma lipid levels exacerbate muscle pathology in the mdx mouse model of Duchenne muscular dystrophy.
    Milad N; White Z; Tehrani AY; Sellers S; Rossi FMV; Bernatchez P
    Skelet Muscle; 2017 Sep; 7(1):19. PubMed ID: 28899419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain function in Duchenne muscular dystrophy.
    Anderson JL; Head SI; Rae C; Morley JW
    Brain; 2002 Jan; 125(Pt 1):4-13. PubMed ID: 11834588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms and Consequences of Cerebellar Purkinje Cell Disinhibition in a Mouse Model of Duchenne Muscular Dystrophy.
    Wu WC; Bradley SP; Christie JM; Pugh JR
    J Neurosci; 2022 Mar; 42(10):2103-2115. PubMed ID: 35064002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation and characterization of neural stem cells from dystrophic mdx mouse.
    Annese T; Corsi P; Ruggieri S; Tamma R; Marinaccio C; Picocci S; Errede M; Specchia G; De Luca A; Frassanito MA; Desantis V; Vacca A; Ribatti D; Nico B
    Exp Cell Res; 2016 May; 343(2):190-207. PubMed ID: 27015747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix metalloproteinase-2 ablation in dystrophin-deficient mdx muscles reduces angiogenesis resulting in impaired growth of regenerated muscle fibers.
    Miyazaki D; Nakamura A; Fukushima K; Yoshida K; Takeda S; Ikeda S
    Hum Mol Genet; 2011 May; 20(9):1787-99. PubMed ID: 21320869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SU9516 Increases α7β1 Integrin and Ameliorates Disease Progression in the mdx Mouse Model of Duchenne Muscular Dystrophy.
    Sarathy A; Wuebbles RD; Fontelonga TM; Tarchione AR; Mathews Griner LA; Heredia DJ; Nunes AM; Duan S; Brewer PD; Van Ry T; Hennig GW; Gould TW; Dulcey AE; Wang A; Xu X; Chen CZ; Hu X; Zheng W; Southall N; Ferrer M; Marugan J; Burkin DJ
    Mol Ther; 2017 Jun; 25(6):1395-1407. PubMed ID: 28391962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigating the role of dystrophin isoform deficiency in motor function in Duchenne muscular dystrophy.
    Chesshyre M; Ridout D; Hashimoto Y; Ookubo Y; Torelli S; Maresh K; Ricotti V; Abbott L; Gupta VA; Main M; Ferrari G; Kowala A; Lin YY; Tedesco FS; Scoto M; Baranello G; Manzur A; Aoki Y; Muntoni F
    J Cachexia Sarcopenia Muscle; 2022 Apr; 13(2):1360-1372. PubMed ID: 35083887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of neuromuscular synapse function abnormalities in multiple Duchenne muscular dystrophy mouse models.
    van der Pijl EM; van Putten M; Niks EH; Verschuuren JJ; Aartsma-Rus A; Plomp JJ
    Eur J Neurosci; 2016 Jun; 43(12):1623-35. PubMed ID: 27037492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormalities in brain structure and biochemistry associated with mdx mice measured by in vivo MRI and high resolution localized (1)H MRS.
    Xu S; Shi D; Pratt SJP; Zhu W; Marshall A; Lovering RM
    Neuromuscul Disord; 2015 Oct; 25(10):764-72. PubMed ID: 26236031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Startle responses in Duchenne muscular dystrophy: a novel biomarker of brain dystrophin deficiency.
    Maresh K; Papageorgiou A; Ridout D; Harrison NA; Mandy W; Skuse D; Muntoni F
    Brain; 2023 Jan; 146(1):252-265. PubMed ID: 35136951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deletion of Galgt2 (B4Galnt2) reduces muscle growth in response to acute injury and increases muscle inflammation and pathology in dystrophin-deficient mice.
    Xu R; Singhal N; Serinagaoglu Y; Chandrasekharan K; Joshi M; Bauer JA; Janssen PM; Martin PT
    Am J Pathol; 2015 Oct; 185(10):2668-84. PubMed ID: 26435413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteasome inhibitor (MG-132) treatment of mdx mice rescues the expression and membrane localization of dystrophin and dystrophin-associated proteins.
    Bonuccelli G; Sotgia F; Schubert W; Park DS; Frank PG; Woodman SE; Insabato L; Cammer M; Minetti C; Lisanti MP
    Am J Pathol; 2003 Oct; 163(4):1663-75. PubMed ID: 14507673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential distribution of the members of the dystrophin glycoprotein complex in mouse retina: effect of the mdx(3Cv) mutation.
    Dalloz C; Claudepierre T; Rodius F; Mornet D; Sahel J; Rendon A
    Mol Cell Neurosci; 2001 May; 17(5):908-20. PubMed ID: 11358487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of dystroglycan as a second laminin receptor in oligodendrocytes, with a role in myelination.
    Colognato H; Galvin J; Wang Z; Relucio J; Nguyen T; Harrison D; Yurchenco PD; Ffrench-Constant C
    Development; 2007 May; 134(9):1723-36. PubMed ID: 17395644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-31 modulates dystrophin expression: new implications for Duchenne muscular dystrophy therapy.
    Cacchiarelli D; Incitti T; Martone J; Cesana M; Cazzella V; Santini T; Sthandier O; Bozzoni I
    EMBO Rep; 2011 Feb; 12(2):136-41. PubMed ID: 21212803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein-Anchoring Therapy of Biglycan for Mdx Mouse Model of Duchenne Muscular Dystrophy.
    Ito M; Ehara Y; Li J; Inada K; Ohno K
    Hum Gene Ther; 2017 May; 28(5):428-436. PubMed ID: 27485975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulation of brain utrophin does not rescue behavioral alterations in dystrophin-deficient mice.
    Perronnet C; Chagneau C; Le Blanc P; Samson-Desvignes N; Mornet D; Laroche S; De La Porte S; Vaillend C
    Hum Mol Genet; 2012 May; 21(10):2263-76. PubMed ID: 22343141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.